Cancer

Items 31-40 of 44

per page
Set Descending Direction
  1. CD38 (human) (rec.) (His) (active) (10µg)
    BBL-2275
    BBL-2275-C01010 µg
    CHF 782.00
    CD38 (human) (rec.) (His) (active) (10µg)
  2. CD40 (human):Fc (human) (rec.)
    AG-40B-0083
    AG-40B-0083-C05050 µg
    CHF 300.00
    AG-40B-0083-30503 x 50 µg
    CHF 600.00
  3. DR6 (human):Fc (human) (rec)
    AG-40B-0011
    AG-40B-0011-C05050 µg
    CHF 170.00
    AG-40B-0011-30503 x 50 µg
    CHF 335.00
  4. Fas (human):Fc (human) (rec.)
    AG-40B-0082
    AG-40B-0082-C05050 µg
    CHF 300.00
    AG-40B-0082-30503 x 50 µg
    CHF 600.00
  5. FasL (human) (multimeric) (rec.)
    AG-40B-0130
    AG-40B-0130-C01010 µg
    CHF 380.00
    AG-40B-0130-30103 x 10 µg
    CHF 760.00
    Oligomerisation of FasL (h) efficiently triggers Jurkat cell death.Method: Jurkat cells were treated O/N with the indicated concentrations of FasL (human) (multimeric) (rec.) (Prod. No. AG-40B-0130), Fc:FasL, Soluble (human) (rec.) (Prod. No.
  6. Fc (human):FasL, Soluble (human) (rec.)
    AG-40B-0132
    AG-40B-0132-C01010 µg
    CHF 335.00
    AG-40B-0132-30103 x 10 µg
    CHF 670.00
    Oligomerisation of FasL (h) efficiently triggers Jurkat cell death.Method: Jurkat cells were treated O/N with the indicated concentrations of MegaFasL, Soluble (human) (rec.) (Prod. No. AG-40B-0130), Fc:FasL, Soluble (human) (rec.) (Pr
  7. IL-2 (human) (rec.) (untagged)
    CHI-HR-20602
    CHI-HR-20602-C01010 µg
    CHF 170.00
  8. PANoptosome Human Antibodies Starter Set
    AG-44B-0012
    AG-44B-0012-KI011 Set
    CHF 650.00
  9. Tim-4 (mouse):Fc (human) (rec.)
    AG-40B-0180
    AG-40B-0180-C05050 µg
    CHF 250.00
    AG-40B-0180-30503 x 50 µg
    CHF 500.00
    Tim-4 (mouse):Fc (human) (rec.)
  10. Tim-4 (mouse):Fc (human) (rec.) (Biotin)
    AG-40B-0180B
    AG-40B-0180B-C01010 µg
    CHF 300.00
    AG-40B-0180B-30103 x 10 µg
    CHF 600.00
    Tim-4 (mouse):Fc (human) (rec.) (Biotin)

Items 31-40 of 44

per page
Set Descending Direction
© 2017 Adipogen Life Sciences. Pictures: © 2012 Martin Oeggerli. All Rights Reserved.